493 related articles for article (PubMed ID: 35662189)
1. From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer's and Parkinson's diseases.
Wakhloo D; Oberhauser J; Madira A; Mahajani S
Neural Regen Res; 2022 Dec; 17(12):2606-2614. PubMed ID: 35662189
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
3. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
4. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
Schulz-Schaeffer WJ
Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
[TBL] [Abstract][Full Text] [Related]
5. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
[TBL] [Abstract][Full Text] [Related]
6. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
8. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
9. Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?
Windisch M; Wolf HJ; Hutter-Paier B; Hofmeister A; Wronski R
Curr Alzheimer Res; 2007 Sep; 4(4):446-57. PubMed ID: 17908049
[TBL] [Abstract][Full Text] [Related]
10. Modeling Parkinson's Disease With the Alpha-Synuclein Protein.
Gómez-Benito M; Granado N; García-Sanz P; Michel A; Dumoulin M; Moratalla R
Front Pharmacol; 2020; 11():356. PubMed ID: 32390826
[TBL] [Abstract][Full Text] [Related]
11. Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.
Kumari R; Kumar R; Kumar S; Singh AK; Hanpude P; Jangir D; Maiti TK
J Biol Chem; 2020 Mar; 295(11):3466-3484. PubMed ID: 32005664
[TBL] [Abstract][Full Text] [Related]
12. Insights Into the Role of Mortalin in Alzheimer's Disease, Parkinson's Disease, and HIV-1-Associated Neurocognitive Disorders.
Priyanka ; Seth P
Front Cell Dev Biol; 2022; 10():903031. PubMed ID: 35859895
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery.
Picca A; Guerra F; Calvani R; Romano R; Coelho-Júnior HJ; Bucci C; Marzetti E
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680141
[TBL] [Abstract][Full Text] [Related]
14. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
16. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
Sato H; Kato T; Arawaka S
Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
[TBL] [Abstract][Full Text] [Related]
17. Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases.
Freyssin A; Page G; Fauconneau B; Rioux Bilan A
Neural Regen Res; 2018 Jun; 13(6):955-961. PubMed ID: 29926816
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson's disease.
Gao Q; Chen R; Wu L; Huang Q; Wang XX; Tian YY; Zhang YD
Neural Regen Res; 2022 May; 17(5):1138-1145. PubMed ID: 34558543
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
Compta Y; Revesz T
J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
